Actos News

Studies Show an Increase in Bladder Cancer for Actos Patients
Friday, August 26, 2011

American Diabetes Association study published in Diabetes Care issue shows increased risk of bladder cancer in patients taking Actos (pioglitazone). Researchers gathered data taken from the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System (AERS) between 2004 and 2009.

 

 

News Archives

Actos News 2014
Actos News 2013
Actos News 2012
Actos News 2011
Tell Us What
Happened to You

*Confirm Email
*State
This field must be blank
*Describe your symptoms

Antidepressants and Birth Defects | Whistleblower Claims | Baum Hedlund Law

Servicios también disponibles en Español | Nous sommes fières d’offrir nos services en Français | 한국어로도 서비스를 제공해 드립니다.
Legal Advertisement | This is Not a Medical Website | Site Disclaimers | Privacy Policy

Martindale-Hubbell is the facilitator of a peer review rating process. Ratings reflect the confidential opinions of members of the Bar and the Judiciary.
Martindale-Hubbell Ratings fall into two categories - legal ability and general ethical standards. AV® Preeminent ™ is a certification mark of Reed Elsevier Properties Inc.,
used in accordance with the Martindale-Hubbell certification procedures, standards and policies.


US News Best Law Firms 2014

The cases represented on this site or our past performance, verdicts, settlements, testimonials or endorsements do not constitute a guarantee, warranty,
or prediction regarding the outcome of future cases.